Drug Profile
pcTG90 gene delivery systems
Latest Information Update: 07 Apr 2003
Price :
$50
*
At a glance
- Originator Transgene
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 07 Apr 2003 No development reported - Preclinical for Cancer in France (IV)
- 12 Jul 2000 New profile
- 12 Jul 2000 Preclinical development for Cancer in France (IV)